Functional neuroimaging as a clinical tool in psychiatry;Funktionelle bildgebung als klinisches instrument in der psychiatrie

Nervenheilkunde

Volumn 18, Issue 7, 1999, Pages 322-331

  Walter, H ^a   Riepe, M W ^b   Groen, G ^b  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

Dementia; Depression; Functional neuroimaging; Obsessive compulsive disorder; Schizophrenia; Treatment response

Indexed keywords

DEMENTIA; DEPRESSION; EARLY DIAGNOSIS; HUMAN; MEDICAL RESEARCH; NEUROANATOMY; OBSESSION; REVIEW; SCHIZOPHRENIA;

EID: 0032722774     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Abercrombie HC, Schaefer SM, Larsson CL et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998; 9: 3301-7.
2. Andreasen NC, O'Leary DS, Flaum M et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic naive patients. Lancet 1997; 3489: 1735-9
3. Andreasen NC. Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science 1997; 275: 1286-593.
4. Bartenstein P. Klinische Anwendung der Positronenemissionstomographie in der Neurologie und Psychiatrie. Nervenheilkunde 1999; 18: 132-7.
5. Bartlett EJ, Brodie JD, Simkowitz P et al. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients. Am J Psychiatry 1998; 155: 337-43.
6. Baxter LE, Schwartz JM, Bergman KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-9.
7. Baxter LR. Neuroimaging studies of human anxiety disorders. In Psychpharmacology: The fourth generation of progress. Bloom FE, Kupfer DJ (Hrsg). Raven Press, New York 1995; 1287-99.
8. Bechara A. Emotionen und Entscheidungs-findung nach Frontalhirnläsionen: Ansätze zum Verständnis bestimmter psychiatrischer Erkrankungen. Nervenheilkunde 1999; 18: 54-9.
9. Bench CJ, Frackowiak RSJ, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psycholog Med 1995; 25: 247-51.
10. Berg EA. A simple objective treatment for measuring flexibility in thinking. J Gen Psychol 1948; 39: 15-22.
11. Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, Schneider F, Weiss U, Flor H. fMRT reveals amygdala activation to human faces in social phobics. NeuroReport 1998; 9: 1223-6.
12. Breiter HC, Rauch SL, Kwong KK et al. Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder. Arch Gen Psychiatry 1996; 35: 595-606.
13. Buchsbaum MS, Potkin SG, Siegel BV et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992; 49: 966-74.
14. Buchsbaum MS, Tang CY, Peled S et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. NeuroReport 1998; 9: 425-30.
15. Callicott JH, Ramsey NF, Tallent K et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory. Neuropsychopharmacology 1998; 18 (3): 186-96.
16. Convit A, de Leon MJ, Golomb J, George AE, Tashish CY, Bobinski M, Tsui W, De Santis S, Wegiel J, Wisniewski H. Hippocampal atrophy in early Alzheimer's disease: anatomic specifity and validation. Psychiat Quart 1993; 64: 371-87.
17. Convit A, de Leon MJ, Tashish CY, De Santis S, Kluger A, Rusinek H, George AE. Hippocampal volume losses in minimally impaired elderly. Lancet 1995; 345: 266.
18. David AS, Busatto G. Die Halluzination. Eine Störung von Geist und Gehirn. Nervenheilkunde 1999; 18: 104-15.
19. Davidson RJ, Abercrombie H, Nitschke JB, Putnam K. Regional brain funtion, emotion and disorders of emotion. Curr Opin Neurobiol 1999; 9: 228-34.
20. Dolan RJ. Functional imaging and the neurobiology of the psychoses. Sem Neurosci 1995; 7: 165-71.
21. Drevets WC, Price JL, Simpson JR, Todd RD, Teich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-7.
22. Ebert D, Ebmeier KP. The role of the cingulate gyrus in depression: from functional neuroanatomy to neurochemistry. Biol Psychiatry 1996; 39: 1044-50.
23. Ebert D, Feistel H, Barocka A, Kaschka W. Increased limbic flow and total sleep deprivation in major depression with melancholia. Psychiatry Res: Neuroimaging 1994; 55: 101-9.
24. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disordes: a study with Tc-99m-HMPAO SPECT. Psychiatry Res: Neuroimaging 1991; 40: 247-51.
25. Ebert D, Hohagen. Strukturelle und funktionelle Neuroanatomie der Zwangsstörung: Untersuchungen mit bildgebenden Verfahren. In: Hohagen F, Ebert D (Hrsg) Neue Perspektiven in Grundlagenforschung und Behandlung der Zwangsstörungen. Solvay 1998: 51-66.
26. Elliott R, Sahakian BJ, Michael A, Paykel ES, Dolan RJ. Abnormal neural response to feedback on planning and guessing tasks in patients with unipolar depression. Psycholog Med 1998; 28: 559-71.
27. Frey KA, Minoshima S, Kuhl DE. Neurochemical imaging of Alzheimer's disease and other degenerative dementias. Q J Nucl Med 1998; 42: 166-78.
28. Frith CD. The cognitive neuropsychology of schizophrenia. Hove, East Sussex: Erlbaum 1992.
29. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996; 16: 4491-500.
30. Gouzoulis-Mayfrank E. Experimentelle Psychoseforschung mit halluzinogenen Substanzen - Geschichte und Gegenwart. Nervenheilkunde 1999; 18: 84-92.
31. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-30.
32. Groen G, Wunderlich A, Grothe J, Tomczak R, Walter H, Riepe MW. Learning and free recall of abstract visual designs: an fmri-study. J Cog Neuroscience 1999; Suppl: 32.
33. Hagen T. Funktionelles Neuroimaging: Single-Photon-Emissions-Computer-Tomographie (SPECT). In: Handbuch Morbus Alzheimer. Weis S & Weber G (Hrsg.). Weinheim: Beltz 1997: 781-802.
34. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI. Longitudinal study of cerebral metabolic assymetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990; 47: 753-60.
35. 2 receptor imaging and neuroleptic drug response. J Clin Psychiatry 1996; 57 (suppl 11): 84-8.
36. Herholz K, Adams R, Kessler, J. Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1990; 1: 156-64.
37. Herholz K. FDG-PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 1995; 9: 6-16.
38. Hyman BT, Van-Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology. 1990; 40: 1721-30.
39. Hyman BT, Van-Hoesen GW. Neuron numbers in Alzheimer's disease: cell-specific pathology. Neurobiol-Aging 1987; 8: 555-6.
40. Hyman BT, Van-Horsen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168-70.
41. Imamura T, Ishii K, Sasaki M, Kitagaki H, Yamaji S, Hirono N, Shimomura T, Hashimoto M, Tanimukai S, Kazui H, Mori E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci-Lett 1997; 235: 49-52.
42. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Hashimoto M, Hirono N, Shimomura T, Mori E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998; 51: 125-30.
43. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivink RJ, Tangalos EG, Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998; 51: 993-9.
44. Kiefer M, Spitzer M. Kognitive Defizite schizophrener Patienten. Nervenheilkunde 1999; 18; 331-6.
45. Ketter AT, George MS, Kimbrell TA, Benson BE, Post RM. Functional brain imaging, limbic function, and affective disorders. Neuroscientist 1996; 2: 55-65.
46. Kleinschmidt A. Funktionelle Magnetresonanztomographie. Einblicke in zerebrale Organisation und Dysfunktion. Nervenheilkunde 1999; 18: 75-8.
47. Kolk BA, Burbridge JA, Suzuki J.. The psychobiology of traumatic memory. Clinical implications of neuroimaging studies. Ann N Y Acad Sci 1997b; 821: 99-133.
48. Kuwert T, Bartenstein P, Grünwald F, Herholz K, Larisch R, Sabri O, Biersack HJ, Moser E, Müller-Gärtner HW, Schober O, Schwaiger M, Büll U, Heiss WD. Klinische Wertigkeit der Positronen-Emissions-Tomographie in der Neuromedizin. Nervenarzt 1998; 69: 1045-60.
49. 2-receptors in striatum and anterior cingulate gyrus in major depression. Neuroimage 1997; 5: 251-60.
50. Lewis S, Higgins N. Brain imaging in psychiatry. Oxford, Blackwell 1996.
51. Liddle PF, Friston KJ, Frith CD et al. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160: 179-89.
52. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996; 153: 174-82.
53. Mayberg-HS. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin Neurosci 1997 Summer; 9: 471-81.
54. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Marin CC, Fox PT. Cingulate function in depression: a potential predictor of treatment response. NeuroReport 1997; 8: 1057-61.
55. Mizutani T, Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci Lett 1997; 222: 119-22.
56. Murashita J, Kato T, Shioiri T, Inubushi T, Kato N. Age-dependent alteration of metabolic response to photic stimulation in the human brain measured by 31P MR-spectroscopy. Brain Res 1999; 818: 72-6.
57. Rapoport SI. Discriminant analysis of brain imaging data identifies subjects with early Alzheimer's disease. Int Psychogeriatr 1997; 9: 229-35; discussion 247-52.
58. Rauch SL, Shin LM. Functional neuroimaging studies in posttraumatic stress disorder. Ann N Y Acad Sci 1997; 821: 83-98.
59. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334:752-8.
60. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de-Leon MJ, De-Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann-Neurol 1998; 44: 288-91.
61. Riepe MW, Huelsmann I, Tomczak R, Walter H, Wunderlich A, Groen G. Decline of visual and verbal memory in aging and Alzheimer's dementia. Neurology 1999; 52 (Suppl): S 121.
62. Sabri O, Erkwoh R, Schreckenberger M et al. Correlation of psoitive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997; 349:1730-4.
63. Sapolsky RM. Why stress is bad for your brain. Science 1996; 273: 749-50.
64. Schneider F, Grodd W, Machulla H-J. Untersuchung psychischer Funktionen durch funktionelle Bildgebung mit Positronenemissionstomographie und Kernspintomographie. Nervenarzt 1996; 67: 721-9.
65. Schröder J, Buchsbaum MS, Siegel BV et al. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schiz Res 1996; 19: 41-53.
66. 2-dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123-I-iodobenzamide single-photon-emission-computed-tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 1998; 43: 660-5.
67. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps ME. Systematic changes in cerbral glucose metabolic rate after succesful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 109-13.
68. Schwarz A, Walter H. Aktuelles Forum: Vom Neuron zum Wahn. Moderne Funktionsdiagnostik des Gehirns. Nervenheilkunde 1998; 17: S1-S30.
69. Servan-Schreiber D, Perlstein WM. Selective limbic activation and its relevance to emotional disorders. Cog Emo 1998; 12: 331-52.
70. Small GW, Komo S, La-Rue A, Saxena S, Phelps ME, Mazziotta JC, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann-N-Y-Acad-Sci 1996; 802: 70-8.
71. Smith EE, Jonides JJ. Neuroimaging analysis of working memory. Proc Natl Acad Sci USA 1998; 95: 12061-8.
72. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiat Res 1997b; 4: 393-432.
73. Spence SA et al. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain 1997; 120: 1997-2011.
74. Spitzer M, Casas B. Project for a scientific psychpathology. Curr Opin Psychiatry 1997; 10: 395-401.
75. Spitzer M, Kammer Th, Bellemann ME, Brix G, Layer B, Maier S, Kischka U, Gückel F. Funktionelle Magnetresonanztomographie in der psychopathologischen Forschung. Fortschritte Neurol Psychiat 1998; 6: 241-58.
76. Szelies B, Heiss WD. Funktionelles Neuroimaging: Positronen-Emissions-Tomographie (PET). In: Handbuch Morbus Alzheimer. Weis S & Weber G (Hrsg.). Weinheim: Beltz 1997: 803-33.
77. van Hoesen GW, Hyman BT, Damasio AR. Cell-specific pathology in neural systems of the temporal lobe in Alzheimer's disease. Prog-Brain-Res. 1986; 70: 321-35.
78. Vogeley K, Falkai P. Brain imaging in schizophrenia. Curr Opin Psychiatry 1999; 12: 41-6.
79. Volk SA, Kaendler SH, Weber R et al. Evaluation of the effects of total sleep deprivation on cerebral blood flow using single photon emission computerized tomography. Acta Pschiatr Scand 1992; 86: 478-83.
80. Volk SA, Keandler SH, Hertel A et al. Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiat Res: Neuroimaging 1997; 75; 67-74.
81. Vollenweider FX. Neue Aspekte der PET-und SPECT-Forschung - Metabolische Korrelate psychotischer Störungen bei Schizophrenen und Modell-Psychosen. In: Fleischhacker WW, Hinterhuber H, Meise U (Hrsg.). Schizophrene Störungen. State of the Art II. Ursachen - Behandlung - Verlauf. Verlag Integrative Psychiatrie Innsbruck 1998; S. 134-54.
82. Walter H, Bretschneider V, Groen G. et al. Cortical activation in fMRI during a working memory task depends on attended stimuli features and encoding strategies. J Cog Neurosci 1999; Suppl: 33.
83. Walter H. Emergence and the cognitive neuroscience of psychiatry. Z für Naturforsch 1998; 53c: 723-737.
84. Walter H. Neurowissenschaft der Emotionen und Psychiatrie. Nervenheilkunde 1999; 18:116-126.
85. Weinberger DR, Berman KF. Prefrontal function in schizophrenia: confounds and controversies. Phil Trans Roy Soc Lond (B) 1996; 351(1246): 1495-503.
86. Weinberger DR, Mattay V, Callicott J, Kotria K, Santha A, von Gelderren P, Duyn J, Moonen C, Frank J. FMRI applications in schizophrenia research. Neuroimage 1996; 4: 8118-26.
87. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149: 538-43.
88. Zald DH, Suck Won Kim AB. Anatomy and function of the orbital frontal cortex. I. Anatomy, neurocircuitry and obsessive compulsive disorder; II: Function and relevance to obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1996; 8: 125-38; 249-61.